Gilmore O'Neill, incoming Editas Medicine CEO

With Ed­i­tas' third CEO in as many years, ex­pect a new CMO and new de­vel­op­ment part­ners

Sarep­ta Ther­a­peu­tics CMO Gilmore O’Neill will take over as CEO and pres­i­dent of CRISPR biotech Ed­i­tas Med­i­cine on June 1.

But al­ready in the hours since be­ing an­nounced, O’Neill has been hear­ing from his net­work on who could po­ten­tial­ly be the new CMO at the gene edit­ing com­pa­ny he’s about to helm. Lisa Michaels was fired from the med­ical chief post in ear­ly Feb­ru­ary, with­out pub­lic ex­pla­na­tion, as part of a re­build­ing of the C-suite.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.